Umpierrez GE, Smiley D, Zisman A, Prieto LM, Palacio A, Ceron M, et al. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial). Diabetes Care. 2007;30(9):2181–6.

Article  CAS  PubMed  Google Scholar 

Umpierrez GE, Smiley D, Jacobs S, Peng L, Temponi A, Mulligan P, et al. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes undergoing general surgery (RABBIT 2 surgery). Diabetes Care. 2011;34(2):256–61.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Christensen MB, Gotfredsen A, Nørgaard K. Efficacy of basal-bolus insulin regimens in the inpatient management of non-critically ill patients with type 2 diabetes: a systematic review and meta-analysis. Diabetes Metab Res Rev. 2017;33(5).

Murad MH, Coburn JA, Coto-Yglesias F, Dzyubak S, Hazem A, Lane MA, et al. Glycemic control in non-critically ill hospitalized patients: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2012;97(1):49–58.

Article  CAS  PubMed  Google Scholar 

McAlister FA, Majumdar SR, Blitz S, Rowe BH, Romney J, Marrie TJ. The relation between hyperglycemia and outcomes in 2,471 patients admitted to the hospital with community-acquired pneumonia. Diabetes Care. 2005;28(4):810–5.

Article  PubMed  Google Scholar 

Bhatti JM, Raza SA, Shahid MO, Akhtar A, Ahmed T, Das B. Association between glycemic control and the outcome in hospitalized patients with COVID-19. Endocrine. 2022;77(2):213–20.

Article  CAS  PubMed  PubMed Central  Google Scholar 

van den Boom W, Schroeder RA, Manning MW, Setji TL, Fiestan G-O, Dunson DB. Effect of A1C and glucose on postoperative mortality in noncardiac and cardiac surgeries. Diabetes Care. 2018;41(4):782–8.

Article  PubMed  Google Scholar 

Kosiborod M, Inzucchi SE, Krumholz HM, Xiao L, Jones PG, Fiske S, et al. Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of risk. Circulation. 2008;117(8):1018–27.

Article  CAS  PubMed  Google Scholar 

Fong KM, Au SY, Ng GWY. Glycemic control in critically ill patients with or without diabetes. BMC Anesthesiol. 2022;22(1):227.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Abdelmalak B, Abdelmalak JB, Knittel J, Christiansen E, Mascha E, Zimmerman R, et al. The prevalence of undiagnosed diabetes in non-cardiac surgery patients, an observational study. Can J Anaesth. 2010;57(12):1058–64.

Article  PubMed  Google Scholar 

Cobas R, Rodacki M, Giacaglia L, Calliari LEP, Noronha RM, Valerio C, et al. Diagnóstico do diabetes e rastreamento do diabetes tipo 2. Diretriz oficial da sociedade brasileira de diabetes. Conectando Pessoas; 2022.

Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab. 2002;87(3):978–82.

Article  CAS  PubMed  Google Scholar 

Greci LS, Kailasam M, Malkani S, Katz DL, Hulinsky I, Ahmadi R, et al. Utility of HbA(1c) levels for diabetes case finding in hospitalized patients with hyperglycemia. Diabetes Care. 2003;26(4):1064–8.

Article  PubMed  Google Scholar 

Pasquel FJ, Gomez-Huelgas R, Anzola I, Oyedokun F, Haw JS, Vellanki P, et al. Predictive value of admission hemoglobin a1c on inpatient glycemic control and response to insulin therapy in medicine and surgery patients with type 2 diabetes. Diabetes Care. 2015;38(12):e202–3.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Weykamp C. HbA1c: a review of analytical and clinical aspects. Ann Lab Med. 2013;33(6):393–400.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Beck RW, Connor CG, Mullen DM, Wesley DM, Bergenstal RM. The fallacy of average: how using hba1c alone to assess glycemic control can be misleading. Diabetes Care. 2017;40(8):994–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gounden V, Ngu M, Anastasopoulou C, Jialal I. Fructosamine. StatPearls. Treasure Island (FL): StatPearls Publishing; 2024.

Toyoshima MTK, Cukier P, Damascena AS, Batista RL, de Azevedo CF, Zanatta Kawahara E, et al. Fructosamine and glycated hemoglobin as biomarkers of glycemic control in people with type 2 diabetes mellitus and cancer (GlicoOnco study). Clinics. 2023;78:100240.

Article  PubMed  PubMed Central  Google Scholar 

Cohen RM, Holmes YR, Chenier TC, Joiner CH. Discordance between HbA1c and fructosamine: evidence for a glycosylation gap and its relation to diabetic nephropathy. Diabetes Care. 2003;26(1):163–7.

Article  CAS  PubMed  Google Scholar 

Vellanki P, Bean R, Oyedokun FA, Pasquel FJ, Smiley D, Farrokhi F, et al. Randomized controlled trial of insulin supplementation for correction of bedtime hyperglycemia in hospitalized patients with type 2 diabetes. Diabetes Care. 2015;38(4):568–74.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pasquel FJ, Gianchandani R, Rubin DJ, Dungan KM, Anzola I, Gomez PC, et al. Efficacy of sitagliptin for the hospital management of general medicine and surgery patients with type 2 diabetes (Sita-Hospital): a multicentre, prospective, open-label, non-inferiority randomised trial. Lancet Diabetes Endocrinol. 2017;5(2):125–33.

Article  CAS  PubMed  Google Scholar 

Pérez-Belmonte LM, Gómez-Doblas JJ, Millán-Gómez M, López-Carmona MD, Guijarro-Merino R, Carrasco-Chinchilla F, et al. Use of linagliptin for the management of medicine department inpatients with type 2 diabetes in Real-World Clinical Practice (Lina-Real-World Study). J Clin Med. 2018;7(9):271.

Article  PubMed  PubMed Central  Google Scholar 

Ribeiro RS, Peres RB, Yamamoto MT, Novaes AP, Laselva CR, Faulhaber ACL, et al. Impact of screening and monitoring of capillary blood glucose in the detection of hyperglycemia and hypoglycemia in non-critical inpatients. Einstein. 2011;9(1):14–7.

Article  PubMed  Google Scholar 

Bowman CF, Nichols JH. Comparison of accuracy guidelines for hospital glucose meters. J Diabetes Sci Technol. 2020;14(3):546–52.

Article  PubMed  PubMed Central  Google Scholar 

Arora S, Henderson SO, Long T, Menchine M. Diagnostic accuracy of point-of-care testing for diabetic ketoacidosis at emergency-department triage: -hydroxybutyrate versus the urine dipstick. Diabetes Care. 2011;34(4):852–4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brooke J, Stiell M, Ojo O. Evaluation of the accuracy of capillary hydroxybutyrate measurement compared with other measurements in the diagnosis of diabetic ketoacidosis: a systematic review. Int J Environ Res Public Health. 2016;13(9):837.

Article  PubMed  PubMed Central  Google Scholar 

Santomauro AT, Santomauro Junior AC, Raduan RA, Bertoluci M. Diagnóstico e tratamento da cetoacidose diabética euglicêmica. Diretriz oficial da sociedade brasileira de diabetes. Conectando Pessoas; 2022.

Douros A, Lix LM, Fralick M, Dell’Aniello S, Shah BR, Ronksley PE, et al. Sodium-glucose cotransporter-2 inhibitors and the risk for diabetic ketoacidosis: a multicenter cohort study. Ann Intern Med. 2020;173(6):417–25.

Article  PubMed  Google Scholar 

Toyoshima MTK, Cukier P, Souza ABC de, Pereira J, Hoff AO, Nery M. Effects of glucocorticoids on interstitial glucose concentrations in individuals with hematologic cancer and without known diagnosis of diabetes: a pilot study. Einstein. 2022;20:eAO8031.

Donihi AC, Raval D, Saul M, Korytkowski MT, DeVita MA. Prevalence and predictors of corticosteroid-related hyperglycemia in hospitalized patients. Endocr Pract. 2006;12(4):358–62.

Article  PubMed  Google Scholar 

Le VT, Ha QH, Tran MT, Le NT, Le VT, Le MK. Hyperglycemia in severe and critical COVID-19 patients: risk factors and outcomes. Cureus. 2022;14(8):e27611.

PubMed  PubMed Central  Google Scholar 

Umpierrez GE, Hellman R, Korytkowski MT, Kosiborod M, Maynard GA, Montori VM, et al. Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2012;97(1):16–38.

Article  CAS  PubMed  Google Scholar 

NICE-SUGAR Study Investigators, Finfer S, Chittock DR, Su SY-S, Blair D, Foster D, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360(13):1283–97.

Moghissi ES, Korytkowski MT, DiNardo M, Einhorn D, Hellman R, Hirsch IB, et al. American association of clinical endocrinologists and American diabetes association consensus statement on inpatient glycemic control. Diabetes Care. 2009;32(6):1119–31.

Article  PubMed  PubMed Central  Google Scholar 

Johnston KC, Bruno A, Pauls Q, Hall CE, Barrett KM, Barsan W, et al. Intensive vs standard treatment of hyperglycemia and functional outcome in patients with acute ischemic stroke: the SHINE randomized clinical trial. JAMA. 2019;322(4):326–35.